ALB and breast carcinoma: Significant risk factors for CIM in breast cancer patients undergoing chemotherapy included Age, BMI, Pathological staging, hemoglobin, Lymphocyte, Diabetes, Liver function, history of radiotherapy, chemotherapy regimen, genetic factors, albumin.